The International Generic and Biosimilar medicines Association (IGBA) announced today the annual leadership change of its CEO Advisory Committee (AC). Vinita Gupta, CEO of Lupin, was appointed Chair and Lucas Sigman, CEO of Insud Pharma, Vice-Chair.
Geneva, November 13, 2023 – In the week ahead, IGBA will renew its commitment to raise awareness of the powerful and lifechanging impact of biosimilar medicines which contribute to delivering better health outcomes and biologics access equity for more patients. The fourth Global Biosimilars Week (GBW) will run from 13th to 17th November, 2023 on social media, supported by a rich resource dedicated website globalbiosimilarsweek.org.
- IGBA and WHO collaborate on expanding access to quality-assured generic and biosimilar medicines (October 2023)
- IGBA’s CEO Advisory Committee Meets with WIPO Director General Daren Tang (October 2023)
- ANAFAM, the National Association of Medicines Manufacturers of Mexico, joins IGBA (September 2023)
- Global regulators and biopharmaceutical and vaccine industry to share experiences with managing pharmaceutical quality systems (July 2023)
